S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
IART · Integra LifeSciences Holdings Corporation
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
Integra Lifesciences Holdings Corp (IART)
NASDAQ NMS - GLOBAL MARKET
Health Care
$11.81
-1.49
(-11.17%)
● At close: October 21 at 4:00:00 PM EDT
$11.84
+0.00
(+0.00%)
After-Hours:
4:26:09 PM EDT
DAY'S RANGE
$11.81
$11.58
$13.74
52-WEEK RANGE
$11.81
$8.70
$20.49
What's happening
- IART is down 11.17% today, trading at $11.81. — Live quote
- Volume today (133,965) is well below its 3-month average of 942,020. (Finnhub fundamentals)
- Reports earnings on 2026-10-21 (before market open), 0 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.59 actual vs. $0.57 estimated (+3.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 4
Buy 4
Hold 8
Sell 2
Strong sell 0
Aggregate ratings for 2026-10-01 (18 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
IART
+7.33%
vs S&P 500
-5.45%
1-YEAR RETURN
IART
-15.04%
vs S&P 500
-29.60%
6-MONTH RETURN
IART
+22.97%
3-MONTH RETURN
IART
-29.88%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-10-21 (Q3 2026)
$0.59
Est. $0.57
BEAT +3.0%
2026-07-26 (Q2 2026)
$0.56
Est. $0.49
BEAT +13.6%
2026-04-26 (Q1 2026)
$0.54
Est. $0.41
BEAT +30.9%
2026-01-26 (Q4 2025)
$0.83
Est. $0.82
BEAT +1.7%
Valuation Measures & Ratios
Enterprise Value4$2.72B
Forward P/E56.25
PEG Ratio61.30
Price / Sales (TTM1)0.65
Price / Book71.34
EV4 / Revenue1.65
EV4 / EBITDA33.91
Profit Margin-0.44%
Operating Margin3.96%
Return on Equity (ROE8)-0.70%
Return on Assets (ROA9)-0.20%
Avg Volume (3M)942,020
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $1.34B | $725.6M | $1.11B | $942.1M | $1.69B |
| P/E | -2.74 | -1.40 | -2.11 | -1.77 | -32.62 |
| Price/Sales | 0.82 | 0.46 | 0.70 | 0.59 | 1.09 |
| Price/Book | 1.29 | 0.70 | 1.07 | 0.91 | 1.11 |
| EV/Revenue | 1.13 | 0.76 | 1.02 | 0.92 | 1.42 |
| ROE | -46.93% | -49.83% | -50.64% | -51.26% | -3.39% |
| ROA | -13.74% | -14.52% | -14.41% | -14.52% | -1.27% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short7,266,960
Change from Prior Settlement+6.77%
% of Float—
Days to Cover (Short Ratio)7.51
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 0.8% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-10-21; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -0.4%. Finnhub fundamentals ↗
- Trailing 52-week price return is -15.0%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on IART
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $418.8M | $391.9M | $402.1M | $415.6M | $382.7M | $380.8M | $418.2M | $368.9M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $19.3M | $11.5M | $11.8M | -$512.7M | -$15.5M | -$8.2M | -$3.0M | $4.0M |
| Net income | $4.5M | -$4.6M | -$5.4M | -$484.1M | -$25.3M | -$10.7M | -$12.4M | -$3.3M |
| EPS (diluted) | $0.06 | $-0.06 | $-0.07 | $-6.31 | $-0.33 | $-0.14 | $-0.16 | $-0.04 |
| EPS (basic) | $0.06 | $-0.06 | $-0.07 | $-6.31 | $-0.33 | $-0.14 | $-0.16 | $-0.04 |
| Operating margin | $5 | $3 | $3 | -$123 | -$4 | -$2 | -$1 | $1 |
| Net margin | $1 | -$1 | -$1 | -$116 | -$7 | -$3 | -$3 | -$1 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $3.56B | $3.58B | $3.60B | $3.65B | $3.67B | $4.05B | $4.04B | $4.07B |
| Total liabilities | $2.52B | $2.54B | $2.56B | $2.61B | $2.63B | $2.53B | $2.49B | $2.54B |
| Stockholders' equity | $1.04B | $1.04B | $1.04B | $1.04B | $1.04B | $1.52B | $1.55B | $1.52B |
| Total current assets | $1.19B | $1.17B | $1.16B | $1.14B | $1.14B | $1.11B | $1.08B | $1.10B |
| Total current liabilities | $330.9M | $346.8M | $456.0M | $364.1M | $929.8M | $918.5M | $922.1M | $912.6M |
| Cash & equivalents | $214.4M | $236.8M | $235.0M | $232.2M | $217.9M | $239.1M | $246.4M | $215.2M |
| Marketable securities (current) | $59.7M | $28.7M | $28.7M | $35.7M | $35.7M | $34.2M | $27.2M | $62.4M |
| Accounts receivable | $267.2M | $264.4M | $278.8M | $262.2M | $284.5M | $252.4M | $272.4M | $248.3M |
| Inventory | $492.0M | $495.0M | $492.7M | $489.1M | $465.1M | $445.4M | $429.1M | $436.9M |
| Other current assets | $53.9M | $49.4M | $28.1M | $30.3M | $36.1M | $32.2M | $29.7M | $50.4M |
| Property, plant & equipment | $446.2M | $446.9M | $444.3M | $437.4M | $434.8M | $422.9M | $405.7M | $390.9M |
| Goodwill | $611.1M | $613.2M | $615.2M | $615.2M | $616.4M | $1.11B | $1.10B | $1.12B |
| Intangible assets | $1.08B | $1.11B | $1.13B | $1.16B | $1.19B | $1.19B | $1.21B | $1.21B |
| Other non-current assets | $31.6M | $35.0M | $37.9M | $42.2M | $46.2M | $53.2M | $66.5M | $54.0M |
| Accrued liabilities | $107.6M | $133.3M | $130.5M | $132.9M | $131.4M | $137.4M | $121.9M | $131.9M |
| Deferred revenue (current) | $11.7M | $11.6M | $11.5M | $11.3M | $11.1M | $10.5M | $10.5M | $10.0M |
| Long-term debt | $707.2M | $716.9M | $726.6M | $736.2M | $745.9M | $755.6M | $760.5M | $765.3M |
| Other non-current liabilities | $194.4M | $195.6M | $204.3M | $233.3M | $253.2M | $160.5M | $146.2M | $189.8M |
| Common stock & paid-in capital | $921.0K | $922.0K | $923.0K | $923.0K | $923.0K | $921.0K | $916.0K | $916.0K |
| Retained earnings | $423.3M | $418.8M | $423.4M | $425.1M | $430.5M | $914.6M | $939.9M | $920.5M |
| Accumulated other comprehensive income (loss) | -$40.2M | -$30.9M | -$30.1M | -$32.0M | -$30.9M | -$24.1M | -$27.6M | -$24.9M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $22.8M | $9.8M | $11.8M | $40.9M | $8.9M | -$11.3M | $50.7M | $22.5M |
| Investing cash flow | -$43.3M | -$14.8M | -$34.9M | -$15.6M | -$21.6M | -$35.9M | -$4.2M | -$10.4M |
| Financing cash flow | -$818.0K | $8.3M | $24.3M | -$10.2M | -$21.1M | $35.4M | -$7.2M | -$19.9M |
| Free cash flow | $10.5M | -$5.0M | -$5.4M | $25.8M | -$11.2M | -$40.2M | $21.1M | -$7.2M |
| Capital expenditures | $12.3M | $14.8M | $17.2M | $15.2M | $20.1M | $28.9M | $29.6M | $29.6M |
| Depreciation & amortization | — | — | — | — | — | — | — | — |
| Share-based compensation | $5.8M | $5.2M | $5.8M | $5.6M | $5.3M | $1.9M | $7.2M | $4.4M |
| Deferred income taxes | -$4.3M | $1.3M | -$10.9M | -$8.7M | -$44.8M | -$1.8M | -$7.0M | -$9.0M |
| Change in accounts receivable | $3.0M | -$13.6M | $16.5M | -$22.5M | $28.0M | -$21.5M | $31.5M | -$28.8M |
| Change in inventory | -$474.0K | $4.3M | $3.3M | $23.3M | $6.4M | $13.7M | $570.0K | $10.3M |
| Purchases of investments | $31.0M | $0 | $0 | $0 | $1.5M | $7.0M | $0 | $0 |
| Other investing activities | — | — | — | — | — | — | — | — |
| Share repurchases | $0 | — | $0 | $0 | $221.0K | — | $2.5M | $0 |
| Tax withholding on stock comp | $214.0K | $1.4M | $137.0K | $199.0K | $225.0K | $2.1M | $136.0K | $171.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $1.64B | $1.61B | $1.54B | $1.56B | $1.54B |
| Gross profit | — | — | — | — | — |
| Operating income | -$493.4M | $28.4M | $111.5M | $238.9M | $197.2M |
| Net income | -$516.5M | -$6.9M | $67.7M | $180.6M | $169.1M |
| EPS (diluted) | $-6.74 | $-0.09 | $0.84 | $2.16 | $1.98 |
| EPS (basic) | $-6.74 | $-0.09 | $0.85 | $2.18 | $2.00 |
| Operating margin | -$30 | $2 | $7 | $15 | $13 |
| Net margin | -$32 | -$0 | $4 | $12 | $11 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $3.60B | $4.04B | $3.78B | $3.89B | $3.78B |
| Total liabilities | $2.56B | $2.49B | $2.19B | $2.09B | $2.10B |
| Stockholders' equity | $1.04B | $1.55B | $1.59B | $1.80B | $1.68B |
| Total current assets | $1.16B | $1.08B | $1.06B | $1.16B | $1.15B |
| Total current liabilities | $456.0M | $922.1M | $307.0M | $320.9M | $340.0M |
| Cash & equivalents | $235.0M | $246.4M | $276.4M | $456.7M | $513.4M |
| Marketable securities (current) | $28.7M | $27.2M | $32.7M | $0 | — |
| Accounts receivable | $278.8M | $272.4M | $259.3M | $263.5M | $231.8M |
| Inventory | $492.7M | $429.1M | $389.6M | $324.6M | $317.4M |
| Other current assets | $28.1M | $29.7M | $32.6M | $31.0M | — |
| Property, plant & equipment | $444.3M | $405.7M | $340.2M | $311.3M | $311.7M |
| Goodwill | $615.2M | $1.10B | $1.06B | $1.04B | $1.01B |
| Intangible assets | $1.13B | $1.21B | $1.07B | $1.13B | $1.15B |
| Other non-current assets | $37.9M | $66.5M | $58.2M | $57.2M | $16.4M |
| Accrued liabilities | $130.5M | $121.9M | $100.8M | $80.0M | $120.5M |
| Deferred revenue (current) | $11.5M | $10.5M | $8.5M | $7.3M | $5.3M |
| Long-term debt | $726.6M | $760.5M | $775.0M | $775.0M | $843.8M |
| Other non-current liabilities | $204.3M | $146.2M | $199.9M | $138.5M | $120.3M |
| Common stock & paid-in capital | $923.0K | $916.0K | $909.0K | $905.0K | $896.0K |
| Retained earnings | $423.4M | $939.9M | $946.9M | $879.1M | $698.6M |
| Accumulated other comprehensive income (loss) | -$30.1M | -$27.6M | -$15.1M | $10.3M | -$45.2M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $50.4M | $129.4M | $140.0M | $264.5M | $312.4M |
| Investing cash flow | -$108.1M | -$390.8M | -$94.2M | -$58.6M | -$161.4M |
| Financing cash flow | $28.3M | $237.9M | -$229.9M | -$252.0M | -$98.2M |
| Free cash flow | -$31.1M | $25.0M | $73.1M | $222.1M | $264.4M |
| Capital expenditures | $81.4M | $104.4M | $66.9M | $42.3M | $48.0M |
| Depreciation & amortization | — | — | — | — | — |
| Share-based compensation | $18.6M | $24.4M | $20.1M | $27.7M | $36.2M |
| Deferred income taxes | -$66.3M | -$20.7M | -$11.9M | -$4.6M | -$2.8M |
| Change in accounts receivable | $485.0K | -$7.4M | -$4.6M | $33.9M | -$7.3M |
| Change in inventory | $46.8M | $28.1M | $59.8M | $29.1M | -$5.4M |
| Purchases of investments | $8.5M | $49.0M | $32.7M | $0 | $0 |
| Other investing activities | — | — | — | — | — |
| Share repurchases | $221.0K | $52.5M | $275.0M | $125.0M | $0 |
| Tax withholding on stock comp | $2.7M | $3.5M | $5.9M | $24.6M | $4.8M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding IART as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 31 filers
Held by These Filers85.0%
Shares Outstanding77,293,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10,684,103 | $191.9M | 13.82% | +3.5% | 2026-08-07 |
| Rubric Capital Management LP | 7,753,934 | $139.3M | 10.03% | +0.0% | 2026-08-14 |
| Invesco Ltd. | 3,749,367 | $67.3M | 4.85% | +7.6% | 2026-08-13 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3,743,093 | $67.2M | 4.84% | +1.5% | 2026-06-30 |
| Morgan Stanley | 3,593,079 | $64.5M | 4.65% | +0.2% | 2026-08-11 |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 3,439,098 | $61.8M | 4.45% | -14.3% | 2026-08-13 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 3,436,006 | $61.7M | 4.45% | -2.6% | 2026-08-12 |
| State Street Corp | 2,946,862 | $52.9M | 3.81% | +2.1% | 2026-08-07 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,946,173 | $52.9M | 3.81% | +1.9% | 2026-06-30 |
| Neuberger Berman Group LLC | 2,364,777 | $42.6M | 3.06% | +11.8% | 2026-08-13 |
| DIMENSIONAL FUND ADVISORS LP | 2,216,653 | $39.8M | 2.87% | -20.1% | 2026-08-11 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,791,635 | $32.2M | 2.32% | +8.1% | 2026-08-12 |
| Goldman Sachs Group Inc | 1,473,719 | $26.5M | 1.91% | -21.5% | 2026-08-14 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,461,104 | $26.2M | 1.89% | +12.4% | 2026-08-14 |
| MILLENNIUM MANAGEMENT LLC | 1,439,747 | $25.9M | 1.86% | +131.2% | 2026-08-14 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,401,476 | $25.2M | 1.81% | -13.1% | 2026-08-14 |
| Sixth Street Partners Management Company, L.P. | 1,401,476 | $25.2M | 1.81% | +0.0% | 2026-08-13 |
| Bank Of America Corp /De/ | 1,329,251 | $23.9M | 1.72% | -6.0% | 2026-08-14 |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 1,023,243 | $18.4M | 1.32% | -3.4% | 2026-08-14 |
| Allianz Asset Management GmbH | 1,005,203 | $18.1M | 1.30% | +13.0% | 2026-08-11 |
| GLENMEDE TRUST CO NA | 948,142 | $17.0M | 1.23% | -3.7% | 2026-08-10 |
| Northern Trust Corp | 828,532 | $14.9M | 1.07% | +8.3% | 2026-08-12 |
| BALYASNY ASSET MANAGEMENT L.P. | 640,666 | $11.5M | 0.83% | -7.7% | 2026-08-13 |
| Quantinno Capital Management LP | 609,132 | $10.9M | 0.79% | +32.6% | 2026-08-13 |
| Invenomic Capital Management LP | 579,036 | $10.4M | 0.75% | -42.7% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-10-12 to 2026-09-01
Recent transactions
- Most recent: Veillon-Berteloot Chantal (EVP & CHRO) — Tax withholding of 1,455 shares on 2026-09-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Veillon-Berteloot Chantal | EVP & CHRO | Tax withholding | 2026-09-01 | 1,455 |
| Knight Lea Daniels | EVP & Chief Financial Officer | Tax withholding | 2026-07-03 | 5,226 |
| Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Tax withholding | 2026-07-01 | 937 |
| BRADLEY KEITH | Director | Tax withholding | 2026-05-09 | 882 |
| HILL BARBARA B | Director | Grant / award | 2026-05-07 | 6,638 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Tax withholding | 2026-03-11 | 861 |
| McBreen Michael J. | EVP & President, CSS | Tax withholding | 2026-03-11 | 7,247 |
| DAVIS ROBERT T. JR. | EVP & President, TT | Tax withholding | 2026-03-11 | 8,487 |
| Poul Mojdeh | President & CEO | Option exercise | 2026-01-06 | 848 |
| GRAVES JEFFREY A | Director | Open market purchase | 2025-11-05 | 9,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-01 | Veillon-Berteloot Chantal | EVP & CHRO | Tax withholding | 1,455 | $16.62 |
| 2026-07-03 | Knight Lea Daniels | EVP & Chief Financial Officer | Tax withholding | 5,226 | $18.05 |
| 2026-07-01 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Tax withholding | 937 | $17.89 |
| 2026-05-09 | BRADLEY KEITH | Director | Tax withholding | 882 | $13.92 |
| 2026-05-07 | HILL BARBARA B | Director | Grant / award | 6,638 | $0.00 |
| 2026-05-07 | HILL BARBARA B | Director | Grant / award | 17,700 | $0.00 |
| 2026-03-11 | Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Tax withholding | 861 | $9.61 |
| 2026-03-11 | Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Option exercise | 18,922 | $0.00 |
| 2026-03-11 | Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Tax withholding | 5,190 | $9.61 |
| 2026-03-11 | McBreen Michael J. | EVP & President, CSS | Tax withholding | 7,247 | $9.61 |
| 2026-03-11 | DAVIS ROBERT T. JR. | EVP & President, TT | Tax withholding | 8,487 | $9.61 |
| 2026-03-11 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Tax withholding | 806 | $9.61 |
| 2026-03-11 | Knight Lea Daniels | EVP & Chief Financial Officer | Tax withholding | 8,089 | $9.61 |
| 2026-03-11 | Veillon-Berteloot Chantal | EVP & CHRO | Tax withholding | 5,420 | $9.61 |
| 2026-03-10 | Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Option exercise | 1,216 | $0.00 |
| 2026-03-10 | Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Tax withholding | 601 | $9.55 |
| 2026-03-10 | McBreen Michael J. | EVP & President, CSS | Tax withholding | 2,354 | $9.55 |
| 2026-03-10 | DAVIS ROBERT T. JR. | EVP & President, TT | Tax withholding | 687 | $9.55 |
| 2026-03-10 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Tax withholding | 341 | $9.55 |
| 2026-01-06 | Poul Mojdeh | President & CEO | Option exercise | 848 | $0.00 |
| 2026-01-06 | Poul Mojdeh | President & CEO | Option exercise | 542 | $0.00 |
| 2026-01-06 | Poul Mojdeh | President & CEO | Tax withholding | 848 | $13.13 |
| 2026-01-06 | Poul Mojdeh | President & CEO | Tax withholding | 542 | $13.13 |
| 2025-11-05 | GRAVES JEFFREY A | Director | Open market purchase | 9,000 | $11.35 |
| 2025-10-12 | Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Option exercise | 11,965 | $0.00 |
| 2025-10-12 | Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Tax withholding | 3,281 | $13.34 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 18:08 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-21 | 8-K | 2026-10-21 | View on SEC.gov → |
| 2026-10-19 | 8-K | 2026-10-19 | View on SEC.gov → |
| 2026-10-09 | 8-K | 2026-10-09 | View on SEC.gov → |
| 2026-10-02 | 8-K | 2026-10-02 | View on SEC.gov → |
| 2026-09-08 | 8-K | 2026-09-08 | View on SEC.gov → |
| 2026-09-04 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-07-29 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-29 | 8-K | 2026-07-29 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-03 | View on SEC.gov → |
Recent news
Headlines about IART (Integra LifeSciences Holdings Corporation). Links open the publisher — we don’t host full articles.
-
Integra LifeSciences (IART) Reports Q3 Revenue In Line with Guid
GuruFocus · 2026-10-21 -
Integra outlines $1.634B-$1.654B 2026 revenue outlook as Cincinnati disruption extends into Q2 2027
Seeking Alpha · 2026-10-21 -
Integra LifeSciences Holdings Corporation (IART) Q3 2026 Earnings Call Transcript
Seeking Alpha · 2026-10-21 -
Integra: 3 Key Takeaways for Long-Term Investors
Yahoo Finance · 2026-10-21 -
Integra LifeSciences Holdings Corporation 2026 Q3 - Results - Earnings Call Presentation
Seeking Alpha · 2026-10-21 -
Integra LifeSciences Holdings Corporation 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:IART) 2026-10-21
Seeking Alpha · 2026-10-21 -
Integra (IART) Q3 2026 Earnings Call Transcript
Yahoo Finance · 2026-10-21 -
Why Integra LifeSciences (IART) stock is falling today
StockStory · 2026-10-21
No headlines in this category right now — try “All”.